Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting
- 1 January 2008
- Vol. 40 (1) , 58-63
- https://doi.org/10.1080/00313020701717720
Abstract
Summary Consensus guidelines on anti-beta 2 glycoprotein I (anti-β2GPI) testing have been developed to help minimise laboratory variation in the performance and reporting of assays for these antibodies. These guidelines include minimum and optional recommendations for the following aspects of anti-β2GPI testing and reporting: (1) isotype of anti-β2GPI tested; (2) specimen type; (3) controls and assay precision; (4) calibrators; (5) patient samples; (6) rheumatoid factors and IgM anti-β2GPI testing; (7) reporting of results; (8) cutoff values; and (9) interpretative comments. Issues related to inter-kit/assay standardisation and the manufacturing process of commercial anti-β2GPI kits/assays have not been addressed in the current guidelines.Keywords
This publication has 45 references indexed in Scilit:
- Antiphospholipid antibody tests: spreading the netAnnals of the Rheumatic Diseases, 2005
- IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosisBlood, 2005
- Antibody profiles for the diagnosis of antiphospholipid syndromeThrombosis and Haemostasis, 2005
- Anti-cardiolipin and anti-β2-glycoprotein I (β2GP-I) antibody assays as screening for anti-phospholipid syndromeHuman Antibodies, 2003
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1Rheumatology, 2003
- Optimising testing for phospholipid antibodiesJournal of Clinical Pathology, 2001
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990